Surles J R, Wykle R L, O'Flaherty J T, Salzer W L, Thomas M J, Snyder F, Piantadosi C
J Med Chem. 1985 Jan;28(1):73-8. doi: 10.1021/jm00379a015.
Platelet-activating factor, 1 (PAF, 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine), and octadecyl-PAF were synthesized chemically as the racemates. The sn-1-O-alkyl isomers were isolated after treatment of the racemates with phospholipase A2 and subsequent reacetylation of the 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholines released. Analogues of PAF containing unsaturated alkyl moieties at the sn-1 position (2, 4, 5) were synthesized by utilizing the methoxyethoxymethyl protecting group as a novel method for preparing unsaturated alkyl lipids. This procedure provides a facile means for preparing unsaturated either phospholipids of defined structure that may be tritiated to high radiospecific activity for metabolic studies. Unsaturation in the alkyl chain had minimal effect on the bioactivities examined in this study.
血小板活化因子1(PAF,1 - O - 十六烷基 - 2 - 乙酰 - sn - 甘油 - 3 - 磷酸胆碱)和十八烷基 - PAF作为外消旋体通过化学合成得到。用磷脂酶A2处理外消旋体,随后对释放出的1 - O - 烷基 - 2 - 溶血 - sn - 甘油 - 3 - 磷酸胆碱进行重新乙酰化,从而分离出sn - 1 - O - 烷基异构体。通过使用甲氧基乙氧基甲基保护基团作为制备不饱和烷基脂质的新方法,合成了在sn - 1位含有不饱和烷基部分的PAF类似物(2、4、5)。该方法为制备具有确定结构的不饱和磷脂提供了一种简便手段,这些磷脂可被氚标记至高放射性比活度用于代谢研究。在本研究中,烷基链中的不饱和度对所检测的生物活性影响极小。